AON-Mediated Exon Skipping for Duchenne Muscular Dystrophy

QR Code

AON-Mediated Exon Skipping for Duchenne Muscular Dystrophy

None

Saved in:

Bibliographic Details
Main Authors:	Verhaart, Ingrid E. C., Aartsma-Rus, Annemieke
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/38140
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Duchenne Muscular Dystrophy: Therapeutic Approaches to Restore Dystrophin
by: Spitali, Pietro, et al.
Published: (2012)

Exon Skipping and Myoblast Transplantation: Single or Combined Potential Options for Treatment of Duchenne Muscular Dystrophy
by: Iannitti, T., et al.
Published: (2012)

Possibility of exon skipping therapy for Duchenne muscular dystrophy in Russian patients: present and future
by: E. V. Zinina, et al.
Published: (2024-09-01)

Duchenne Muscular Dystrophy and Brain Function
by: Anderson, J.L., et al.
Published: (2012)

Progress and Challenges in AAV-Mediated Gene Therapy for Duchenne Muscular Dystrophy
by: Takeda, Shin'Ichi, et al.
Published: (2011)

Muscle Satellite Cells and Duchenne Muscular Dystrophy
by: Miyagoe-Suzuki, Yuko, et al.
Published: (2012)

Altered Gene Expression Pathways in Duchenne Muscular Dystrophy
by: Juretić, Nevenka, et al.
Published: (2012)

Genetic Therapy for Duchenne Muscular Dystrophy: Principles and Progress
by: Koo, Taeyoung, et al.
Published: (2012)

Duchenne Muscular Dystrophy: Experimental models on Physical Therapy
by: Gaiad, Thais, et al.
Published: (2012)

Psychosocial Support Needs of Families of Boys with Duchenne Muscular Dystrophy
by: Mah, Jean K., et al.
Published: (2012)

BREAKTHROUGH IN DUCHENNE MUSCULAR DYSTROPHY TREATMENT
by: article Editorial
Published: (2022-07-01)

Myogenic Potential of Murine Embryonic Stem Cells in the Dmdmdx Mouse Model for Duchenne Muscular Dystrophy
by: Ayub-Guerrieri, Danielle, et al.
Published: (2011)

Duchenne Muscular Dystrophy: Modern Approaches in Patient Management
by: Inga V. Anisimova, et al.
Published: (2023-11-01)

Postural control in early stages of Duchenne muscular dystrophy
by: Cristhina Bonilha Huster Siegle, et al.
Published: (2025-06-01)

Computer task performance by subjects with Duchenne muscular dystrophy
by: Malheiros SR, et al.
Published: (2015-12-01)

Current and emerging treatment strategies for Duchenne muscular dystrophy
by: Mah J
Published: (2016-07-01)

Diagnosis of the Muscular Dystrophies
by: Waddell, Leigh B., et al.
Published: (2012)

Consensus concept of modern effective therapy for Duchenne muscular dystrophy
by: T. A. Gremyakova, et al.
Published: (2023-06-01)

The experience of using ataluren in Duchenne muscular dystrophy in Moscow: first results
by: T. N. Kekeeva, et al.
Published: (2024-01-01)

Rehabilitation in Muscular Dystrophies: Changing Approach
by: Groot, Imelda J.M. de, et al.
Published: (2012)

Advances in Molecular Analysis of Muscular Dystrophies
by: Ankala, Arunkanth, et al.
Published: (2012)

Efficacy and safety of Viltepso® in Duchenne muscular dystrophy: review of clinical studies
by: V. M. Suslov, et al.
Published: (2024-11-01)

Database of Wards for Patients with Muscular Dystrophy in Japan
by: Saito, Toshio, et al.
Published: (2012)

Strength and Functional Measurement for Patients with Muscular Dystrophy
by: Lu, Yen-Mou, et al.
Published: (2012)

The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
by: T. A. Gremyakova, et al.
Published: (2022-06-01)

Is cardiac autonomic modulation influenced by beta blockers in adolescents with Duchenne Muscular Dystrophy?
by: Silva-Magalhães Talita Dias da, et al.
Published: (2025-07-01)

Cardiac involvement in female elite athletes with carrier status of Duchenne muscular dystrophy
by: Simon Wernhart, et al.
Published: (2025-07-01)

Duchenne muscular dystrophy - disease characterization and emergent genetic therapy - literature review
by: Anna Teresa Michalska, et al.
Published: (2025-07-01)

DWORF expression is reduced in a large animal model of Duchenne muscular dystrophy
by: Aaron M. Gibson, et al.
Published: (2025-06-01)

“CIRCLE OF GOOD” APPROVED A NEW DRUG FOR CHILDREN WITH DUCHENNE MUSCULAR DYSTROPHY
by: article Editorial
Published: (2024-09-01)

Abnormal Ion Homeostasis and Cell Damage in Muscular Dystrophy
by: Iwata, Yuko, et al.
Published: (2012)

Opinion of the Italian Association of Myology on Ataluren for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy
by: Luca Bello, et al.
Published: (2025-05-01)

Predicting trajectories of the north star ambulatory assessment total score in Duchenne muscular dystrophy.
by: Francesco Muntoni, et al.
Published: (2025-01-01)

Predicting trajectories of the north star ambulatory assessment total score in Duchenne muscular dystrophy
by: Francesco Muntoni, et al.
Published: (2025-01-01)

Modern methods of therapy of Duchenne muscular dystrophy: literature review with a clinical case
by: S. B. Artemyeva, et al.
Published: (2024-01-01)

Assessment of walking in patients with Duchenne muscular dystrophy receiving ataluren in real clinical practice
by: D. V. Aizatulina, et al.
Published: (2025-04-01)

Nuclear Poly (A)-Binding Protein and Oculopharyngeal Muscular Dystrophy
by: Bag, Jnanankur, et al.
Published: (2012)

Generation and differentiation of an induced pluripotent stem cell line (FMCPGHi006-A) from a patient with Duchenne muscular dystrophy carrying exons 42–43 deletion in the DMD gene
by: Yue Chang, et al.
Published: (2025-09-01)

Facioscapulohumeral Muscular Dystrophy: From Clinical Data to Molecular Genetics and Return
by: Salani, Monica, et al.
Published: (2012)

Association between triglycerides and remnant cholesterol levels and spine bone mineral density in Duchenne muscular dystrophy
by: Yayu Wang, et al.
Published: (2025-06-01)